Early onset of tenofovir-induced renal failure: Case report and review of the literature

TheScientificWorldJournal

Volumn 7, Issue , 2007, Pages 1140-1148

  Patel, Shilpa M ^a   Zembower, Teresa R ^a   Palella, Frank ^a   Kanwar, Yashpal S ^a   Ahya, Shubhada N ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Acute renal failure; Highly active antiretroviral therapy (HAART); Human immunodeficiency virus (HIV); Tenofovir disoproxil fumarate (tenofovir, TDF)

Indexed keywords

ABACAVIR; DIDANOSINE; EFAVIRENZ; LAMIVUDINE; LOPINAVIR; NELFINAVIR; RITONAVIR; STAVUDINE; TENOFOVIR; ZIDOVUDINE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; DRUG WITHDRAWAL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERSENSITIVITY REACTION; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FAILURE; LABORATORY TEST; MALE; PHYSICAL EXAMINATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADENINE; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIOPSY; HIV INFECTIONS; HUMANS; KIDNEY FAILURE; LIVER; MALE; PHOSPHONIC ACIDS; TIME FACTORS; TREATMENT OUTCOME;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 34547602331     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2007.164     Document Type: Article

References (27)

1. Schooley, R., Ruane, P., Myers, R., et al. (2002) Tenofovir DF in antiretroviral-experienced patients: results from a 48-week, randomized, double-blind study. AIDS 16, 1257-1263.
2. Barditch-Crovo, P., Deeks, S., Collier, A., et al. (2001) Phase I/II trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults. Antimicrob. Agents Chemother. 45(10), 2733-2739.
3. Margot, N., Isaacson, E., McGowan, I., Cheng, A., Schooley, R., and Miller, M. (2002) Genotypic and phenotypic analyses of HIV-1 in antiretroviral-experienced patients treated with tenofovir DF. AIDS 16, 1227-1235.
4. st ed. pp. 329-336.
5. Coca, S. and Perazella, M. (2002) Rapid communication: acute renal failure associated with tenofovir: evidence of drug-induced nephrotoxicity. Am. J. Med. Sci. 324(6), 342-344.
6. Verhelst, D., Monge, M., Meynard, J.L., et al. (2002) Fanconi syndrome and renal failure induced by tenofovir: a first case report. Am. J. Kidney Dis. 40, 1331-1333.
7. Hansen, A.B., Mathiesen, S., and Gerstoft, J. (2004) Severe metabolic acidosis and renal failure in an HIV-1 patient receiving tenofovir. Scand. J. Infect. Dis. 36(5), 389-392.
8. Creput, C., Gonzalez-Canali, G., Hill, G., Piketty, C., Kazatchkine, M., and Nochy, D. (2003) Renal lesions in HIV-1 positive patient treated with tenofovir. AIDS 17(6), 935-937.
9. Barrios, A., Garcia-Benayas, T., Gonzalez-Lahoz, J., and Soriano, V. (2004) Tenofovir-related nephrotoxicity in HIV infected patients. AIDS 18, 960-963.
10. Peyrière, H., Reynes, J., Rouanet, I., et al. (2004) Renal tubular dysfunction associated with tenofovir therapy: report of 7 cases. J. Acquir. Immune Defic. Syndr. 35, 269-273.
11. Murphy, M., O'Hearn, M., and Chou, S. (2003) Fatal lactic acidosis and acute renal failure after addition of tenofovir to an antiretroviral regimen containing didanosine. Clin. Infect. Dis. 36, 1082-1085.
12. Schaaf, B., Aries, S.P., Kramme, E., Steinhoff, J., and Dalhoff, K. (2003) Acute renal failure associated with tenofovir treatment in a patient with acquired immunodeficiency syndrome. Clin. Infect. Dis. 37, e41-43.
13. Callens, S., De Roo, A., and Colebunders, R. (2003) Letter to the Editor - Fanconi-like syndrome and rhabdomyolysis in a person with HIV infection on highly active antiretroviral therapy including tenofovir. J. Infect. 47, 262-263.
14. Gaspar, G., Monereo, A., García-Reyne, A., and Guzmán, M. (2004) Fanconi syndrome and acute renal failure in a patient treated with tenofovir: a call for caution. AIDS 18, 351-352.
15. Earle, K.E., Seneviratne, T., Shaker, J., and Shoback, D. (2004) Fanconi syndrome in HIV+ adults: report of 3 cases and literature review. J. Bone Miner. Res. 19, 714-721.
16. Karras, A., Lafaurie, M., Furco, A., et al. (2003) Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: three cases of renal failure, Fanconi syndrome, and nephrogenic diabetes insipidus. Clin. Infect. Dis. 36, 1070-1073.
17. Lee, J.C. and Marosok, R.D. (2003) Acute tubular necrosis in a patient receiving tenofovir. AIDS 17, 2543-2544.
18. Rifkin, B.S. and Perazella, M.A. (2004) Tenofovir associated nephrotoxicity: Fanconi syndrome and renal failure. Am. J. Med. 117, 282-284.
19. James, C.W., Steinhaus, M.C., Szabo, S., and Dressler, R.M. (2004) Tenofovir-related nephrotoxicity: case report and review of the literature. Pharmacotherapy 24, 415-418.
20. Breton, G., Alexandre, M., Duval, X., et al. (2004) Tubulopathy consecutive to tenofovir-containing antiretroviral therapy in two patients infected with human immunodeficiency virus-1. Scand. J. Infect. Dis. 36(6-7), 527-528.
21. Rollot, F., Nazal, E.M., Chauvelot-Moachon, L., et al. (2003) Tenofovir-related Fanconi syndrome with nephrogenic diabetes insipidus in a patient with acquired immunodeficiency syndrome: the role of lopinavir-ritonavir-didanosine. Clin. Infect. Dis. 37, e174-176.
22. Gupta, S.K., Eustace, J.A., Winston, J.A., et al. (2005) Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medical Association of the Infectious Disease Society of America. Clin. Infect. Dis. 40, 1559-1585.
23. U.S. Food and Drug Administration (2003) FDA Report: Background Package for NDA: VIREAD (tenofovir disoproxil fumarate). Available at: http://www.fda.gov/cder/approval/v.htm.
24. th Conference on Retroviruses and Opportunistic Infections (Boston). Foundation for Retrovirology and Human Health, Alexandria, VA. p. 819.
25. th Conference on Retroviruses and Opportunistic Infections (Boston). Foundation for Retrovirology and Human Health, Alexandria, VA. p. 820.
26. Perazella, M. (2000) Acute renal failure in HIV-infected patients: a brief review of common causes. Am. J. Med. Sci. 319(6), 385-391.
27. Gallant, J.E., Parish, M.A., Keruly, J.C., and Moore, R.D. (2005) Changes in Renal Function in Patients Treated with Tenofovir DF (TDF Compared to Nucleoside Reverse Transcriptase Inhibitors (NRTI's). The 3rd IAS Conference on HIV Pathogenesis and Treatment, July, Rio de Janiero, Brazil. Abstract no. TuPe2.3C18.